Showing results (181-190 of 195) with videos related to
Sort By:
Pageof 20
The New England Journal of Medicine|January 27, 1983
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTHS L Hauser, D M Dawson, J R Lehrich, et al.Neurology|May 25, 2011
Vitamin D in African Americans with multiple sclerosisJ M Gelfand, B A C Cree, J McElroy, et al.The Journal of Clinical Investigation|September 1, 1994
In healthy primates, circulating autoreactive T cells mediate autoimmune diseaseC P Genain, D Lee-Parritz, M H Nguyen, et al.Neurology|July 26, 2006
Men transmit MS more often to their children vs women: the Carter effectO H Kantarci, L F Barcellos, E J Atkinson, et al.Neurology|May 1, 1993
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment GroupH L Weiner, G A Mackin, E J Orav, et al.Human Immunology|September 15, 1996
Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretionA Garcia-Merino, C A Alper, K Usuku, et al.Neurology|June 8, 2011
Common viruses associated with lower pediatric multiple sclerosis riskE Waubant, E M Mowry, L Krupp, et al.Neurology|May 20, 2009
Quality of life in multiple sclerosis is associated with lesion burden and brain volume measuresE M Mowry, A Beheshtian, E Waubant, et al.Neurology|May 10, 2006
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answersR M Burwick, P P Ramsay, J L Haines, et al.Genes and Immunity|July 1, 2011
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosisK Vandenbroeck, J Alvarez, B Swaminathan, et al.Pageof 20